Phase II Study to Assess the Safety and Immunogenicity of recMAGE-A3+AS15 ASCI With or Without Poly IC:LC
Clinical trial NCT01437605 · TERMINATED
Trial details
- NCT number
- NCT01437605
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-11
- Primary completion
- 2018-07-18
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.